Voricole Eye Drops contain Voriconazole 1% w/w, a potent antifungal ophthalmic solution used for treating ocular fungal infections including keratitis, conjunctivitis, and post-surgical fungal complications.
Voriconazole inhibits fungal cell membrane synthesis, providing rapid infection control and symptom relief while minimizing ocular damage. Its formulation ensures safe, effective, and targeted antifungal therapy.
Clinically, Voricole Eye Drops are used in eye hospitals, clinics, and diagnostic centers, supporting high patient compliance and therapeutic reliability.
From a business perspective, Voricole Eye Drops strengthen the antifungal ophthalmic segment, offering strong prescription demand, repeat orders, and high PCD pharma franchise growth potential at a best price for franchise partners.